25.03.2025 – 08:01ARTTIC Innovation GmbHSGLT2 HYPE: New EU-funded Project Aims to Transform Hypertension TreatmentSGLT2 HYPE websitemore
07.03.2025 – 07:31STADA Arzneimittel AG3Press Release STADA’s growth journey continues in 2024 - Significant increase in sales and profits - Growing ahead of the marketOne documentmore
14.01.2025 – 12:00LTS Lohmann Therapie-Systeme AGLTS wins funding from BARDA’s Patch Forward Prize Competition for two partnershipsmore
14.01.2025 – 11:15Helmholtz Zentrum MünchenSCP-Nano: A New Technology to Visualize Nanocarriers in Cells and Tissuesmore
09.01.2025 – 10:27Grünenthal GroupGrünenthal appoints Prof. Dr. Uli Brödl as Chief Scientific Officermore
19.12.2024 – 11:43RHEACELL GmbH und Co. KGRHEACELL receives EMA approval for allo-APZ2-CVU Phase 3 trial in chronic venous ulcersmore
16.12.2024 – 10:27Gerresheimer AGGerresheimer: FDA grants Tentative Approval of SQ Innovation’s Lasix® ONYU*more
29.11.2024 – 11:30Strides Pharma International AGStrides Pharma Consolidates European Business-to-Business Operations in Switzerlandmore
25.11.2024 – 13:52Helmholtz Zentrum MünchenInceptor Regulates Insulin Homeostasis: A New Approach for Diabetes Therapiesmore
16.10.2024 – 14:00ARTTIC Innovation GmbHEvent Announcement: VIROFIGHT Hybrid SymposiumRegister HereOne documentmore
24.09.2024 – 12:25RHEACELL GmbH und Co. KGRHEACELL announces FDA approval for Phase 3 study in refractory, non-curable CVUmore
09.09.2024 – 09:06Sysmex Europe SE2Fundació Puigvert validates a new tool capable of selecting the most suitable antibiotic for uncomplicated urinary tract infections within 45 minutes.Visit our website!One documentmore
04.09.2024 – 15:13Fördergesellschaft IZB mbH2Record financing rounds at the Munich biotech hubFind out more about the 40+ biotech start-ups at the IZBOne documentmore
28.08.2024 – 07:34STADA Arzneimittel AGPress release: STADA continues strong growth journey in the first half of 2024One documentmore
17.07.2024 – 09:42Grünenthal Group2Grünenthal announces significant investments in its Latin America production sites, further securing reliable medicine supply for patientsmore
28.05.2024 – 14:05ARTTIC Innovation GmbHcanSERV invites applications for "Revolutionising Cancer Patient Care"canSERV Challenge CallOne documentmore
28.05.2024 – 14:00ARTTIC Innovation GmbH3canSERV invites applications for "Revolutionising Cancer Patient Care"canSERV CallOne documentmore
29.04.2024 – 13:00Gerresheimer AG2Gerresheimer partners with RxCap to offer connected adherence solutionsmore
10.04.2024 – 11:00Dr. Reddy's Laboratories SADr. Reddy's subsidiary betapharm, and Theranica launch Nerivio® in Germany to provide patients with drug-free migraine treatmentmore
14.03.2024 – 07:31STADA Arzneimittel AGPress release: STADA continues with double-digit sales and profit growth in 2023One documentmore
28.02.2024 – 15:00RHEACELL GmbH und Co. KGResearch Success in Rare Disease / RHEACELL receives positive signal for accelerated stem cell development program in rare ‚Butterfly Disease‘more
28.02.2024 – 13:00LTS Lohmann Therapie-Systeme AGFirst product based on LTS’ Sorrel(TM) wearable drug delivery platform launched in the USmore
28.02.2024 – 11:07Helmholtz Zentrum MünchenRising Focus on 'Inceptor' as a Type 2 Diabetes Therapeutic Targetmore
22.02.2024 – 13:23Helmholtz Zentrum MünchenTherapeutic Vaccine for Chronic Hepatitis B Enters Clinical TrialMore information on the therapeutic vaccine TherVacBmore
26.01.2024 – 13:50Biomay AGBiomay Announces its Successful Support of Approval of First CRISPR/Cas9-based Therapymore
24.01.2024 – 11:00SHL MedicalSHL Medical partners with SteriPack Group to set up final assembly servicemore
09.01.2024 – 11:02STADA Arzneimittel AGPress release: Zuellig Pharma becomes STADA Philippines’ exclusive distribution partnerOne documentmore
19.12.2023 – 13:00LTS Lohmann Therapie-Systeme AGLTS receives $4.3 Million grant for the development of contraceptive Microneedle Array Patchesmore